↓ Skip to main content

Dove Medical Press

Adalimumab in the management of Behçet’s disease

Overview of attention for article published in Therapeutics and Clinical Risk Management, April 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

patent
1 patent
wikipedia
1 Wikipedia page

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
44 Mendeley
Title
Adalimumab in the management of Behçet’s disease
Published in
Therapeutics and Clinical Risk Management, April 2015
DOI 10.2147/tcrm.s56163
Pubmed ID
Authors

Atsuhisa Ueda, Mitsuhiro Takeno, Yoshiaki Ishigatsubo

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Unknown 43 98%

Demographic breakdown

Readers by professional status Count As %
Other 8 18%
Student > Ph. D. Student 5 11%
Student > Bachelor 4 9%
Researcher 4 9%
Student > Postgraduate 4 9%
Other 11 25%
Unknown 8 18%
Readers by discipline Count As %
Medicine and Dentistry 25 57%
Social Sciences 2 5%
Computer Science 2 5%
Agricultural and Biological Sciences 1 2%
Nursing and Health Professions 1 2%
Other 5 11%
Unknown 8 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 August 2021.
All research outputs
#5,446,994
of 25,374,647 outputs
Outputs from Therapeutics and Clinical Risk Management
#275
of 1,323 outputs
Outputs of similar age
#64,268
of 279,170 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#7
of 39 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 279,170 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.